Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities:
Net income/(loss)	$ 6,131	$ (14,963)
Adjustments to reconcile net income/(loss) to net cash flows from operating activities
Depreciation	446	168
Accretion of debt discount and loan costs	142	11,374
Amortization of intangible assets	3,515	3,187
Provision for inventory obsolescence	72	149
Stock-based compensation expense	6,306	2,711
Changes in assets and liabilities:
Accounts receivable	(9,336)	(11,252)
Inventories	(6,534)	(4,716)
Prepaid expenses and other assets	1,670	(110)
Accounts payable and accrued liabilities	2,617	9,078
Taxes payable	(40)	0
Net cash flows provided by/(used in) operating activities	4,989	(4,374)
Investing activities:
Product acquisitions	0	(20,674)
Acquisitions of equipment	0	(79)
Net cash flows used in investing activities	0	(20,753)
Financing activities:
Proceeds from issuance of common stock	0	48,000
Equity issuance costs	0	(410)
Proceeds from notes payable	20,000	60,000
Proceeds from exercise of stock options	2,569	1,070
Payment on note payable	0	(67,346)
Loss on refinancing of former debt	0	(2,794)
Payment on deferred financing fees	(437)	0
Net cash flows provided by financing activities	22,132	38,520
Net change in cash and cash equivalents	27,121	13,393
Cash and cash equivalents at beginning of period	63,888	43,822
Cash and cash equivalents at end of period	91,009	57,215
Cash paid for interest	$ 3,095	$ 3,831